Valproate/Lamotrigine and Growth Retardation
Growth and bone metabolism were evaluated in 27 boys and 26 girls, aged 3 to 17 years (mean 9.2 yrs), with epilepsy treated with valproate (VPA) and/or lamotrigine (LTG) for >2 years, in a study at McMaster University and Children’s Hospital, Hamilton, Ontario, Canada.
Sparad:
| Huvudupphov: | |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Pediatric Neurology Briefs Publishers
2001-12-01
|
| Serie: | Pediatric Neurology Briefs |
| Ämnen: | |
| Länkar: | https://www.pediatricneurologybriefs.com/articles/1715 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|